active surveillance in 2021 part 2: imaging and biomarkers
Published 3 years ago • 2.7K plays • Length 25:24Download video MP4
Download video MP3
Similar videos
-
20:50
active surveillance 2021 - from bench to bedside
-
20:23
active surveillance criteria and follow-up protocol
-
15:10
imaging and biomarkers in patient selection for focal ablation
-
23:37
active surveillance who is the right patient and what is the right protocol
-
20:39
active surveillance or: shrinking the gray zone
-
12:46
what role do markers play in establishing active surveillance or definitive care?
-
28:33
active surveillance results and implications of prospective studies
-
6:05
biomarkers to guide active surveillance
-
12:13
biomarkers’ integration with clinical parameters, imaging, and prognostic instruments
-
20:44
active surveillance 2021 (part 3) - patient selection, monitoring, and innocuous interventions
-
26:28
active surveillance from biology to bedside
-
11:13
active surveillance in favorable intermediate-risk prostate cancer
-
12:19
active surveillance 2022: who qualifies, who does not and how should it be monitored
-
1:58
integrated diagnostics and patient selection for active surveillance and treatment
-
11:39
urologic debate part 2: mri vs. molecular markers: which one should i use? markers perspective
-
21:30
next generation biomarkers: as reflex, combination, or first line?
-
11:05
the mir scientific sentinel assay
-
34:00
active surveillance – when can you continue watching and when do you intervene?
-
6:43
in my opinion: biomarkers for the diagnosis of prostate cancer